Global Drug-Eluting Bioabsorbable Stents Market Research Report 2025(Status and Outlook)

March 2025 | 171 pages | ID: GF9357D1AAD4EN
Bosson Research

Abstracts

Report Overview

Drug-eluting bioabsorbable stents are medical devices used in the treatment of coronary artery disease. These stents are designed to slowly dissolve over time, reducing the risk of long-term complications associated with traditional metallic stents. The drug-eluting component of these stents helps to prevent restenosis, a condition where the artery narrows again after the stent is implanted. By combining drug delivery with a bioabsorbable material, these stents offer a promising solution for patients requiring coronary artery intervention.

The market for drug-eluting bioabsorbable stents is experiencing significant growth driven by several key factors. One of the primary market drivers is the increasing prevalence of coronary artery disease globally, leading to a higher demand for effective treatment options. Additionally, advancements in stent technology and materials have improved the efficacy and safety profile of drug-eluting bioabsorbable stents, making them a preferred choice for many physicians and patients. Moreover, the growing focus on minimally invasive procedures and the shift towards personalized medicine are further fueling the adoption of these innovative stents in the healthcare industry.

This report provides a deep insight into the global Drug-Eluting Bioabsorbable Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug-Eluting Bioabsorbable Stents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug-Eluting Bioabsorbable Stents market in any manner.

Global Drug-Eluting Bioabsorbable Stents Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Medtronic

B.Braun Melsungen

Abbott Laboratories

Boston Scientific Corporation

Biosensors International

Terumo Corporation.

MicroPort Scientific Corporation

Alvimedica

Biotronik

Elixir Medical Corporation

Innovative Health Technologies

Market Segmentation (by Type)

Serolimus and Paclitaxel Drug-Eluting Stents

Sirolimus Drug Eluting Stents

Market Segmentation (by Application)

Coronary Artery Diseases

Peripheral Artery Diseases

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Drug-Eluting Bioabsorbable Stents Market
• Overview of the regional outlook of the Drug-Eluting Bioabsorbable Stents Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Eluting Bioabsorbable Stents Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Drug-Eluting Bioabsorbable Stents
1.2 Key Market Segments
  1.2.1 Drug-Eluting Bioabsorbable Stents Segment by Type
  1.2.2 Drug-Eluting Bioabsorbable Stents Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 DRUG-ELUTING BIOABSORBABLE STENTS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 DRUG-ELUTING BIOABSORBABLE STENTS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Drug-Eluting Bioabsorbable Stents Product Life Cycle
3.3 Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2020-2025)
3.4 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug-Eluting Bioabsorbable Stents Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Drug-Eluting Bioabsorbable Stents Manufacturing Sites, Area Served, Product Type
3.8 Drug-Eluting Bioabsorbable Stents Market Competitive Situation and Trends
  3.8.1 Drug-Eluting Bioabsorbable Stents Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Drug-Eluting Bioabsorbable Stents Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 DRUG-ELUTING BIOABSORBABLE STENTS INDUSTRY CHAIN ANALYSIS

4.1 Drug-Eluting Bioabsorbable Stents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF DRUG-ELUTING BIOABSORBABLE STENTS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Drug-Eluting Bioabsorbable Stents Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Drug-Eluting Bioabsorbable Stents Market
5.7 ESG Ratings of Leading Companies

6 DRUG-ELUTING BIOABSORBABLE STENTS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2020-2025)
6.3 Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Type (2020-2025)
6.4 Global Drug-Eluting Bioabsorbable Stents Price by Type (2020-2025)

7 DRUG-ELUTING BIOABSORBABLE STENTS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Eluting Bioabsorbable Stents Market Sales by Application (2020-2025)
7.3 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) by Application (2020-2025)
7.4 Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2020-2025)

8 DRUG-ELUTING BIOABSORBABLE STENTS MARKET SALES BY REGION

8.1 Global Drug-Eluting Bioabsorbable Stents Sales by Region
  8.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Region
  8.1.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region
8.2 Global Drug-Eluting Bioabsorbable Stents Market Size by Region
  8.2.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Region
  8.2.2 Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region
8.3 North America
  8.3.1 North America Drug-Eluting Bioabsorbable Stents Sales by Country
  8.3.2 North America Drug-Eluting Bioabsorbable Stents Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country
  8.4.2 Europe Drug-Eluting Bioabsorbable Stents Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region
  8.5.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Drug-Eluting Bioabsorbable Stents Sales by Country
  8.6.2 South America Drug-Eluting Bioabsorbable Stents Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Region
  8.7.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 DRUG-ELUTING BIOABSORBABLE STENTS MARKET PRODUCTION BY REGION

9.1 Global Production of Drug-Eluting Bioabsorbable Stents by Region(2020-2025)
9.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2020-2025)
9.3 Global Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drug-Eluting Bioabsorbable Stents Production
  9.4.1 North America Drug-Eluting Bioabsorbable Stents Production Growth Rate (2020-2025)
  9.4.2 North America Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drug-Eluting Bioabsorbable Stents Production
  9.5.1 Europe Drug-Eluting Bioabsorbable Stents Production Growth Rate (2020-2025)
  9.5.2 Europe Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drug-Eluting Bioabsorbable Stents Production (2020-2025)
  9.6.1 Japan Drug-Eluting Bioabsorbable Stents Production Growth Rate (2020-2025)
  9.6.2 Japan Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drug-Eluting Bioabsorbable Stents Production (2020-2025)
  9.7.1 China Drug-Eluting Bioabsorbable Stents Production Growth Rate (2020-2025)
  9.7.2 China Drug-Eluting Bioabsorbable Stents Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Medtronic
  10.1.1 Medtronic Basic Information
  10.1.2 Medtronic Drug-Eluting Bioabsorbable Stents Product Overview
  10.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.1.4 Medtronic Business Overview
  10.1.5 Medtronic SWOT Analysis
  10.1.6 Medtronic Recent Developments
10.2 B.Braun Melsungen
  10.2.1 B.Braun Melsungen Basic Information
  10.2.2 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Overview
  10.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.2.4 B.Braun Melsungen Business Overview
  10.2.5 B.Braun Melsungen SWOT Analysis
  10.2.6 B.Braun Melsungen Recent Developments
10.3 Abbott Laboratories
  10.3.1 Abbott Laboratories Basic Information
  10.3.2 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Overview
  10.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.3.4 Abbott Laboratories Business Overview
  10.3.5 Abbott Laboratories SWOT Analysis
  10.3.6 Abbott Laboratories Recent Developments
10.4 Boston Scientific Corporation
  10.4.1 Boston Scientific Corporation Basic Information
  10.4.2 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
  10.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.4.4 Boston Scientific Corporation Business Overview
  10.4.5 Boston Scientific Corporation Recent Developments
10.5 Biosensors International
  10.5.1 Biosensors International Basic Information
  10.5.2 Biosensors International Drug-Eluting Bioabsorbable Stents Product Overview
  10.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.5.4 Biosensors International Business Overview
  10.5.5 Biosensors International Recent Developments
10.6 Terumo Corporation.
  10.6.1 Terumo Corporation. Basic Information
  10.6.2 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Overview
  10.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.6.4 Terumo Corporation. Business Overview
  10.6.5 Terumo Corporation. Recent Developments
10.7 MicroPort Scientific Corporation
  10.7.1 MicroPort Scientific Corporation Basic Information
  10.7.2 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
  10.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.7.4 MicroPort Scientific Corporation Business Overview
  10.7.5 MicroPort Scientific Corporation Recent Developments
10.8 Alvimedica
  10.8.1 Alvimedica Basic Information
  10.8.2 Alvimedica Drug-Eluting Bioabsorbable Stents Product Overview
  10.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.8.4 Alvimedica Business Overview
  10.8.5 Alvimedica Recent Developments
10.9 Biotronik
  10.9.1 Biotronik Basic Information
  10.9.2 Biotronik Drug-Eluting Bioabsorbable Stents Product Overview
  10.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.9.4 Biotronik Business Overview
  10.9.5 Biotronik Recent Developments
10.10 Elixir Medical Corporation
  10.10.1 Elixir Medical Corporation Basic Information
  10.10.2 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Overview
  10.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.10.4 Elixir Medical Corporation Business Overview
  10.10.5 Elixir Medical Corporation Recent Developments
10.11 Innovative Health Technologies
  10.11.1 Innovative Health Technologies Basic Information
  10.11.2 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Overview
  10.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Market Performance
  10.11.4 Innovative Health Technologies Business Overview
  10.11.5 Innovative Health Technologies Recent Developments

11 DRUG-ELUTING BIOABSORBABLE STENTS MARKET FORECAST BY REGION

11.1 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast
11.2 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country
  11.2.3 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region
  11.2.4 South America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Drug-Eluting Bioabsorbable Stents by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Drug-Eluting Bioabsorbable Stents by Type (2026-2033)
  12.1.2 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Drug-Eluting Bioabsorbable Stents by Type (2026-2033)
12.2 Global Drug-Eluting Bioabsorbable Stents Market Forecast by Application (2026-2033)
  12.2.1 Global Drug-Eluting Bioabsorbable Stents Sales (K Units) Forecast by Application
  12.2.2 Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug-Eluting Bioabsorbable Stents Market Size Comparison by Region (M USD)
Table 5. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Drug-Eluting Bioabsorbable Stents Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Eluting Bioabsorbable Stents as of 2024)
Table 10. Global Market Drug-Eluting Bioabsorbable Stents Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Drug-Eluting Bioabsorbable Stents Manufacturing Sites and Area Served
Table 12. Manufacturers Drug-Eluting Bioabsorbable Stents Product Type
Table 13. Global Drug-Eluting Bioabsorbable Stents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Drug-Eluting Bioabsorbable Stents Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Drug-Eluting Bioabsorbable Stents Sales by Type (K Units)
Table 25. Global Drug-Eluting Bioabsorbable Stents Market Size by Type (M USD)
Table 26. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Type (2020-2025)
Table 27. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2020-2025)
Table 28. Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) by Type (2020-2025)
Table 29. Global Drug-Eluting Bioabsorbable Stents Market Size Share by Type (2020-2025)
Table 30. Global Drug-Eluting Bioabsorbable Stents Price (USD/Unit) by Type (2020-2025)
Table 31. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Application
Table 32. Global Drug-Eluting Bioabsorbable Stents Market Size by Application
Table 33. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2020-2025) & (K Units)
Table 34. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2020-2025)
Table 35. Global Drug-Eluting Bioabsorbable Stents Market Size by Application (2020-2025) & (M USD)
Table 36. Global Drug-Eluting Bioabsorbable Stents Market Share by Application (2020-2025)
Table 37. Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2020-2025)
Table 38. Global Drug-Eluting Bioabsorbable Stents Sales by Region (2020-2025) & (K Units)
Table 39. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2020-2025)
Table 40. Global Drug-Eluting Bioabsorbable Stents Market Size by Region (2020-2025) & (M USD)
Table 41. Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region (2020-2025)
Table 42. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2020-2025) & (K Units)
Table 43. North America Drug-Eluting Bioabsorbable Stents Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2020-2025) & (K Units)
Table 45. Europe Drug-Eluting Bioabsorbable Stents Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size by Region (2020-2025) & (M USD)
Table 48. South America Drug-Eluting Bioabsorbable Stents Sales by Country (2020-2025) & (K Units)
Table 49. South America Drug-Eluting Bioabsorbable Stents Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size by Region (2020-2025) & (M USD)
Table 52. Global Drug-Eluting Bioabsorbable Stents Production (K Units) by Region(2020-2025)
Table 53. Global Drug-Eluting Bioabsorbable Stents Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2020-2025)
Table 55. Global Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Medtronic Basic Information
Table 61. Medtronic Drug-Eluting Bioabsorbable Stents Product Overview
Table 62. Medtronic Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Medtronic Business Overview
Table 64. Medtronic SWOT Analysis
Table 65. Medtronic Recent Developments
Table 66. B.Braun Melsungen Basic Information
Table 67. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Overview
Table 68. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. B.Braun Melsungen Business Overview
Table 70. B.Braun Melsungen SWOT Analysis
Table 71. B.Braun Melsungen Recent Developments
Table 72. Abbott Laboratories Basic Information
Table 73. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Overview
Table 74. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories SWOT Analysis
Table 77. Abbott Laboratories Recent Developments
Table 78. Boston Scientific Corporation Basic Information
Table 79. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
Table 80. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Boston Scientific Corporation Business Overview
Table 82. Boston Scientific Corporation Recent Developments
Table 83. Biosensors International Basic Information
Table 84. Biosensors International Drug-Eluting Bioabsorbable Stents Product Overview
Table 85. Biosensors International Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Biosensors International Business Overview
Table 87. Biosensors International Recent Developments
Table 88. Terumo Corporation. Basic Information
Table 89. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Overview
Table 90. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Terumo Corporation. Business Overview
Table 92. Terumo Corporation. Recent Developments
Table 93. MicroPort Scientific Corporation Basic Information
Table 94. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Overview
Table 95. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. MicroPort Scientific Corporation Business Overview
Table 97. MicroPort Scientific Corporation Recent Developments
Table 98. Alvimedica Basic Information
Table 99. Alvimedica Drug-Eluting Bioabsorbable Stents Product Overview
Table 100. Alvimedica Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Alvimedica Business Overview
Table 102. Alvimedica Recent Developments
Table 103. Biotronik Basic Information
Table 104. Biotronik Drug-Eluting Bioabsorbable Stents Product Overview
Table 105. Biotronik Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Biotronik Business Overview
Table 107. Biotronik Recent Developments
Table 108. Elixir Medical Corporation Basic Information
Table 109. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Overview
Table 110. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Elixir Medical Corporation Business Overview
Table 112. Elixir Medical Corporation Recent Developments
Table 113. Innovative Health Technologies Basic Information
Table 114. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Overview
Table 115. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Innovative Health Technologies Business Overview
Table 117. Innovative Health Technologies Recent Developments
Table 118. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2026-2033) & (K Units)
Table 119. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region (2026-2033) & (M USD)
Table 120. North America Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2026-2033) & (K Units)
Table 121. North America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2026-2033) & (M USD)
Table 122. Europe Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2026-2033) & (K Units)
Table 123. Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. South America Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2026-2033) & (K Units)
Table 127. South America Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2026-2033) & (Units)
Table 129. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2026-2033) & (K Units)
Table 131. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2026-2033) & (M USD)
Table 132. Global Drug-Eluting Bioabsorbable Stents Price Forecast by Type (2026-2033) & (USD/Unit)
Table 133. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) Forecast by Application (2026-2033)
Table 134. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Drug-Eluting Bioabsorbable Stents
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Eluting Bioabsorbable Stents Market Size (M USD), 2024-2033
Figure 5. Global Drug-Eluting Bioabsorbable Stents Market Size (M USD) (2020-2033)
Figure 6. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Eluting Bioabsorbable Stents Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drug-Eluting Bioabsorbable Stents Product Life Cycle
Figure 13. Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturers in 2024
Figure 14. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers in 2024
Figure 15. Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Drug-Eluting Bioabsorbable Stents Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drug-Eluting Bioabsorbable Stents Revenue in 2024
Figure 18. Industry Chain Map of Drug-Eluting Bioabsorbable Stents
Figure 19. Global Drug-Eluting Bioabsorbable Stents Market PEST Analysis
Figure 20. Global Drug-Eluting Bioabsorbable Stents Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Drug-Eluting Bioabsorbable Stents Market Share by Type
Figure 27. Sales Market Share of Drug-Eluting Bioabsorbable Stents by Type (2020-2025)
Figure 28. Sales Market Share of Drug-Eluting Bioabsorbable Stents by Type in 2024
Figure 29. Market Size Share of Drug-Eluting Bioabsorbable Stents by Type (2020-2025)
Figure 30. Market Size Share of Drug-Eluting Bioabsorbable Stents by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Drug-Eluting Bioabsorbable Stents Market Share by Application
Figure 33. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2020-2025)
Figure 34. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2024
Figure 35. Global Drug-Eluting Bioabsorbable Stents Market Share by Application (2020-2025)
Figure 36. Global Drug-Eluting Bioabsorbable Stents Market Share by Application in 2024
Figure 37. Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2020-2025)
Figure 38. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2020-2025)
Figure 39. Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region (2020-2025)
Figure 40. North America Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2024
Figure 43. North America Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Drug-Eluting Bioabsorbable Stents Market Size Market Share by Country in 2024
Figure 45. U.S. Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Drug-Eluting Bioabsorbable Stents Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Drug-Eluting Bioabsorbable Stents Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Drug-Eluting Bioabsorbable Stents Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Drug-Eluting Bioabsorbable Stents Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2024
Figure 53. Europe Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Drug-Eluting Bioabsorbable Stents Market Size Market Share by Country in 2024
Figure 55. Germany Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2024
Figure 67. Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region in 2024
Figure 68. China Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (K Units)
Figure 79. South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2024
Figure 80. South America Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (M USD)
Figure 81. South America Drug-Eluting Bioabsorbable Stents Market Size Market Share by Country in 2024
Figure 82. Brazil Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Drug-Eluting Bioabsorbable Stents Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Drug-Eluting Bioabsorbable Stents Production Market Share by Region (2020-2025)
Figure 103. North America Drug-Eluting Bioabsorbable Stents Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Drug-Eluting Bioabsorbable Stents Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Drug-Eluting Bioabsorbable Stents Production (K Units) Growth Rate (2020-2025)
Figure 106. China Drug-Eluting Bioabsorbable Stents Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Drug-Eluting Bioabsorbable Stents Market Share Forecast by Type (2026-2033)
Figure 111. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2026-2033)
Figure 112. Global Drug-Eluting Bioabsorbable Stents Market Share Forecast by Application (2026-2033)